Sertraline treatment of generalized social phobia: A 20-week, double-blind, placebo-controlled study

American Journal of Psychiatry

Volumn 158, Issue 2, 2001, Pages 275-281

  Van Ameringen, M A ^a   Lane, R M ^a   Walker, J R ^a   Bowen, R C ^a   Chokka, P R ^a   Goldner, E M ^a   Johnston, D G ^a   Lavallee, Y J ^a   Nandy, S ^a   Pecknold, J C ^a   Hadrava, V ^a   Swinson, R P ^a  

^a MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; ARTICLE; ASTHENIA; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; FEMALE; FLU LIKE SYNDROME; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SOCIAL PHOBIA; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

ADULT; DIARRHEA; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NAUSEA; PHOBIC DISORDERS; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; SLEEP INITIATION AND MAINTENANCE DISORDERS; TREATMENT OUTCOME;

EID: 0035146313     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.158.2.275     Document Type: Article

References (30)

1. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey
2. Functional impairment in social phobia
3. How shy is too shy?
4. Social phobia: Epidemiology, recognition and treatment
5. Social phobia in general health care: An unrecognized undertreated disabling disorder
6. Advances in behavioral-cognitive therapy of social phobia
7. Cognitive-behavior and pharmacological treatment of social phobia
8. Pharmacotherapy of social phobia: A controlled study with moclobemide and phenelzine
9. Phenelzine vs atenolol in social phobia
10. Social phobia: The clinical efficacy and tolerability of the monoamine oxidase-A and serotonin reuptake inhibitor brofaromine: A double-blind placebo-controlled study
11. Treatment of social phobia with clonazepam and placebo
12. Moclobemide in social phobia: A controlled dose-response trial
13. Placebo-controlled trial of moclobemide in social phobia
14. Sertraline for social phobia: A double-blind, placebocontrolled crossover study
15. Psychopharmacological treatment of social phobia: A double-blind, placebocontrolled study with fluvoxamine
16. Paroxetine treatment of generalized social phobia (social anxiety disorder): A randomized, double-blind, placebo-controlled study
17. Fluvoxamine treatment of social phobia (social anxiety disorder): A double-blind, placebo-controlled study
18. A new depression scale designed to be sensitive to change
19. Brief standard self-rating for phobic patients
20. The Brief Social Phobia Scale
21. The Brief Social Phobia Scale: A psychometric evaluation
22. Pharmacotherapy of social phobia: An interim report of a placebo-controlled comparison of phenelzine and atenolol
23. An empirically derived inventory to measure social fears and anxiety: The Social Phobia and Anxiety Inventory
24. Measurement of social-evaluative anxiety
25. The Clinical Anxiety Scale: An instrument derived from the Hamilton Anxiety Scale
26. Assessing impairment in patients with panic disorder: The Sheehan Disability Scale